Usefulness of an RNA extraction-free test for the multiplexed detection of ALK , ROS1 , and RET gene fusions in in real life FFPE specimens of non-small cell lung cancers

FDA Approves Pralsetinib for Treatment of Adults with Metastatic RET Fusion-Positive NSCLC

(2020) Kevin Wright   ONCOLOGY-NEW YORK

Evaluation of commercially available small RNASeq library preparation kits using low input RNA

(2018) Ashish Yeri et al.   BMC GENOMICS

Targeting RET in Patients With RET-Rearranged Lung Cancers: Results From the Global, Multicenter RET Registry

(2017) Oliver Gautschi et al.   JOURNAL OF CLINICAL ONCOLOGY

Prospective Comprehensive Molecular Characterization of Lung Adenocarcinomas for Efficient Patient Matching to Approved and Emerging Therapies

(2017) Emmet J. Jordan et al.   Cancer Discovery

Multiplexed transcriptome analysis to detect ALK, ROS1 and RET rearrangements in lung cancer

(2017) Toni-Maree Rogers et al.   Scientific Reports

French multicentric validation ofALKrearrangement diagnostic in 547 lung adenocarcinomas

(2015) Sylvie Lantuejoul et al.   EUROPEAN RESPIRATORY JOURNAL

KIF5B-RET fusions in lung adenocarcinoma

(2012) Takashi Kohno et al.   NATURE MEDICINE